Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 29.68%68.08M | 2.59%187.5M | 11.85%22.89M | 8.69%57.39M | -1.85%54.73M | -2.31%52.5M | -24.34%182.76M | -64.83%20.46M | -12.95%52.8M | -11.41%55.76M |
Net interest income | 20.74%52.27M | 7.32%188.6M | 25.72%53.13M | 11.45%46.91M | -1.91%45.28M | -4.31%43.29M | -11.92%175.74M | -13.38%42.26M | -18.84%42.09M | -11.31%46.16M |
-Net interest income | 4.59%89.18M | 14.15%356.48M | 11.78%93.35M | 13.43%90.89M | 13.16%86.98M | 18.76%85.26M | 32.31%312.31M | 24.30%83.51M | 30.29%80.13M | 35.79%76.87M |
-Interest income from loans and lease | 11.21%74.46M | 19.03%291.07M | 17.02%76.75M | 19.82%75.49M | 18.63%71.88M | 20.93%66.95M | 40.95%244.54M | 28.95%65.58M | 38.42%63M | 49.30%60.59M |
-Interest income from securities | -11.45%12.23M | -11.24%55.73M | -12.12%13.12M | -8.53%14.44M | -9.09%14.36M | -15.16%13.81M | 0.91%62.79M | -8.13%14.92M | -0.78%15.79M | -1.13%15.8M |
-Other interest income | -44.70%2.49M | 94.89%9.68M | 16.00%3.49M | -28.15%957K | 55.37%738K | 2,839.22%4.5M | 1,523.20%4.97M | 3,522.89%3.01M | 1,949.23%1.33M | 1,004.65%475K |
-Total interest expense | -12.07%36.91M | 22.93%167.88M | -2.51%40.22M | 15.63%43.98M | 35.80%41.7M | 58.04%41.98M | 273.99%136.56M | 124.16%41.26M | 294.76%38.04M | 572.83%30.71M |
-Interest expense for deposit | -8.54%25.6M | 33.99%115.04M | 1.61%27.82M | 24.62%30.79M | 50.05%28.45M | 88.88%27.99M | 382.10%85.86M | 160.23%27.38M | 500.19%24.7M | 1,030.47%18.96M |
-Interest expense for long term debt and capital securities | -19.15%11.31M | 4.21%52.84M | -10.63%12.41M | -1.05%13.19M | 12.81%13.26M | 19.11%13.99M | 171.06%50.7M | 76.04%13.88M | 141.55%13.33M | 307.00%11.75M |
Non interest income | 71.66%15.81M | -115.75%-1.11M | -38.75%-30.24M | -2.18%10.48M | -1.59%9.45M | 8.33%9.21M | -83.31%7.02M | -332.02%-21.79M | 21.76%10.71M | -11.93%9.6M |
-Total premiums earned | 12.42%335K | -64.95%1.3M | -49.09%335K | -66.92%349K | -68.67%318K | -69.62%298K | 14.55%3.71M | -12.38%658K | 29.61%1.06M | -12.73%1.02M |
-Fees and commissions | 1.11%7.54M | 6.53%30.2M | 0.10%7.16M | 8.68%7.73M | 8.90%7.85M | 8.51%7.46M | -3.48%28.34M | 7.65%7.15M | 10.63%7.11M | 6.42%7.21M |
-Other non interest income | 778.36%7.26M | -13.70%2.33M | -66.83%338K | -19.09%780K | 8.88%380K | 128.45%827K | 18.57%2.69M | 26.74%1.02M | 738.26%964K | -24.30%349K |
-Gain loss on sale of assets | 6.87%669K | -25.95%-34.93M | -24.32%-38.07M | 2.53%1.62M | -12.59%896K | 119.65%626K | -487.01%-27.73M | -2,660.28%-30.62M | 9.78%1.58M | -59.02%1.03M |
Credit losses provision | -70.93%-1.38M | -119.15%-5.39M | 8.08%-1.17M | -296.96%-1.04M | -248.38%-2.37M | -232.64%-805K | -235.41%-2.46M | -1,946.38%-1.27M | -143.76%-263K | -183.33%-680K |
Non interest expense | 5.29%38.31M | 9.52%154.76M | 14.91%43.65M | 9.10%38.24M | 4.64%36.48M | 8.93%36.39M | 2.55%141.3M | 10.33%37.99M | -1.06%35.05M | 2.93%34.87M |
Occupancy and equipment | 4.40%3.7M | 0.16%13.38M | 5.25%3.43M | -2.31%3.21M | -1.75%3.19M | -0.48%3.55M | 0.24%13.36M | -0.58%3.26M | -0.30%3.28M | 1.85%3.25M |
Professional expense and contract services expense | 36.08%826K | 3.33%2.73M | -4.66%736K | -4.38%676K | 12.80%714K | 13.88%607K | 43.52%2.65M | 11.24%772K | 28.08%707K | 123.67%633K |
Selling and administrative expenses | 9.79%23.7M | 10.14%93.28M | 15.95%26.76M | 7.84%23.03M | 4.27%21.9M | 12.13%21.59M | 2.23%84.69M | 13.31%23.08M | 0.35%21.36M | 1.30%21M |
-General and administrative expense | 9.79%23.7M | 10.14%93.28M | 15.95%26.76M | 7.84%23.03M | 4.27%21.9M | 12.13%21.59M | 2.23%84.69M | 13.31%23.08M | 0.35%21.36M | 1.30%21M |
Depreciation amortization depletion | -6.42%816K | -5.79%3.4M | -6.64%843K | -6.53%844K | -6.53%844K | -3.43%872K | -2.43%3.61M | -2.38%903K | -2.48%903K | -2.38%903K |
-Depreciation and amortization | -6.42%816K | -5.79%3.4M | -6.64%843K | -6.53%844K | -6.53%844K | -3.43%872K | -2.43%3.61M | -2.38%903K | -2.48%903K | -2.38%903K |
Other non-interest expense | -5.21%9.27M | 13.43%41.97M | 19.15%11.88M | 19.11%10.48M | 8.35%9.84M | 6.77%9.78M | 2.56%37M | 8.80%9.97M | -6.12%8.8M | 3.86%9.08M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -305K | |||||||||
Less:Restructuring and mergern&acquisition | --305K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 83.50%28.08M | -29.87%27.35M | -16.69%-21.93M | 3.52%18.11M | -21.48%15.87M | -23.82%15.31M | -63.06%39M | -178.93%-18.8M | -32.30%17.49M | -29.89%20.22M |
Income tax | 215.14%4.14M | -173.33%-8.08M | -272.16%-11.05M | -105.84%-75K | 19.35%1.73M | -29.47%1.31M | -9.51%11.02M | 142.32%6.42M | -36.21%1.28M | -63.47%1.45M |
Earnings from equity interest net of tax | ||||||||||
Net income | 71.13%23.94M | 26.62%35.43M | 56.84%-10.88M | 12.19%18.18M | -24.64%14.14M | -23.24%13.99M | -70.04%27.98M | -219.14%-25.22M | -31.97%16.21M | -24.52%18.76M |
Net Income continuous operations | 71.13%23.94M | 26.62%35.43M | 56.84%-10.88M | 12.19%18.18M | -24.64%14.14M | -23.24%13.99M | -70.04%27.98M | -219.14%-25.22M | -31.97%16.21M | -24.52%18.76M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 71.13%23.94M | 26.62%35.43M | 56.84%-10.88M | 12.19%18.18M | -24.64%14.14M | -23.24%13.99M | -70.04%27.98M | -219.14%-25.22M | -31.97%16.21M | -24.52%18.76M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 71.13%23.94M | 26.62%35.43M | 56.84%-10.88M | 12.19%18.18M | -24.64%14.14M | -23.24%13.99M | -70.04%27.98M | -219.14%-25.22M | -31.97%16.21M | -24.52%18.76M |
Basic earnings per share | 71.88%0.55 | 26.56%0.81 | 56.90%-0.25 | 13.51%0.42 | -25.58%0.32 | -23.81%0.32 | -70.09%0.64 | -218.37%-0.58 | -32.73%0.37 | -24.56%0.43 |
Diluted earnings per share | 68.75%0.54 | 25.00%0.8 | 56.90%-0.25 | 10.81%0.41 | -25.58%0.32 | -23.81%0.32 | -70.09%0.64 | -220.83%-0.58 | -32.73%0.37 | -24.56%0.43 |
Dividend per share | 0.00%0.16 | 0.00%0.64 | 0.00%0.16 | 0.00%0.16 | 0.00%0.16 | 0.00%0.16 | 1.59%0.64 | 0.00%0.16 | 0.00%0.16 | 0.00%0.16 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |